PE20140634A1 - N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-iliden)metil)benzamida - Google Patents

N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-iliden)metil)benzamida

Info

Publication number
PE20140634A1
PE20140634A1 PE2012001060A PE2012001060A PE20140634A1 PE 20140634 A1 PE20140634 A1 PE 20140634A1 PE 2012001060 A PE2012001060 A PE 2012001060A PE 2012001060 A PE2012001060 A PE 2012001060A PE 20140634 A1 PE20140634 A1 PE 20140634A1
Authority
PE
Peru
Prior art keywords
methyl
iliden
quinolin
benzamide
piperidin
Prior art date
Application number
PE2012001060A
Other languages
English (en)
Inventor
Khanh Bui
Cathy Dantzman
Glen Ernst
Valerie Hoesch
Thomas Hudzik
Megan Murphy King
Jie Liu
Jingbo Yan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PE20140634A1 publication Critical patent/PE20140634A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A UN COMPUESTO TAL COMO N-(2-HIDROXIETIL)-N-METIL-4-(QUINOLIN-8-IL(1-(TIAZOL-4-ILMETIL)PIPERIDIN-4-ILIDEN)METIL)BENZAMIDA. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION QUE COMPRENDE: A) HACER REACCIONAR 2-(METILAMINO)ETANOL CON 4-[BROMO-(4-CARBOXI-FENIL)-METILEN]-PIPERIDINA PROTEGIDA PARA OBTENER 4-(BROMO-{4-[(2-HIDROXI-ETIL)-METIL-CARBAMOIL]-FENIL}-METILEN)-PIPERIDINA PROTEGIDA; B) HACER REACCIONAR 4-(BROMO-{4-[(2-HIDROXI-ETIL)-METIL-CARBAMOIL]-FENIL}-METILEN)-PIPERIDINA PROTEGIDA CON ACIDO 8-QUINOLINBORICO PARA FORMAR N-(2-HIDROXI-ETIL)-N-METIL-4-(PIPERIDIN-4-ILIDEN-QUINOLIN-8-IL-METIL)-BENZAMIDA PROTEGIDA; C) DESPROTEGER EL COMPUESTO OBTENIDO EN EL PASO (B); Y D) HACER REACCIONAR N-(2-HIDROXI-ETIL)-N-METIL-4-(PIPERIDIN-4-ILIDEN-QUINOLIN-8-IL-METIL)-BENZAMIDA CON TIAZOL-4-CARBALDEHIDO PARA FORMAR N-(2-HIDROXIETIL)-N-METIL-4-(QUINOLIN-8-IL(1-(TIAZOL-4-ILMETIL)PIPERIDIN-4-ILIDEN)METIL)BENZAMIDA
PE2012001060A 2006-10-20 2012-07-24 N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-iliden)metil)benzamida PE20140634A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86232706P 2006-10-20 2006-10-20

Publications (1)

Publication Number Publication Date
PE20140634A1 true PE20140634A1 (es) 2014-06-19

Family

ID=39314285

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2007001423A PE20080892A1 (es) 2006-10-20 2007-10-19 N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-iliden)metil)benzamida
PE2012001060A PE20140634A1 (es) 2006-10-20 2012-07-24 N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-iliden)metil)benzamida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2007001423A PE20080892A1 (es) 2006-10-20 2007-10-19 N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-iliden)metil)benzamida

Country Status (33)

Country Link
US (2) US7659286B2 (es)
EP (1) EP2079735B1 (es)
JP (1) JP4668346B2 (es)
KR (1) KR20090065534A (es)
CN (1) CN101528739B (es)
AR (1) AR063345A1 (es)
AT (1) ATE543818T1 (es)
AU (2) AU2007313515B2 (es)
BR (1) BRPI0717631A2 (es)
CA (1) CA2667041C (es)
CL (1) CL2007003009A1 (es)
CO (1) CO6180450A2 (es)
CY (1) CY1112718T1 (es)
DK (1) DK2079735T3 (es)
ES (1) ES2379519T3 (es)
HK (1) HK1131556A1 (es)
HR (1) HRP20120344T1 (es)
IL (1) IL197876A0 (es)
MX (1) MX2009003974A (es)
MY (1) MY148880A (es)
NO (1) NO20091969L (es)
NZ (1) NZ577060A (es)
PE (2) PE20080892A1 (es)
PL (1) PL2079735T3 (es)
PT (1) PT2079735E (es)
RS (1) RS52260B (es)
RU (1) RU2454414C2 (es)
SA (1) SA07280549B1 (es)
SI (1) SI2079735T1 (es)
TW (1) TW200826939A (es)
UA (1) UA97648C2 (es)
UY (1) UY30652A1 (es)
WO (1) WO2008048171A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1641757A1 (en) * 2003-05-16 2006-04-05 AstraZeneca AB Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
MY148880A (en) 2006-10-20 2013-06-14 Astrazeneca Ab N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression
KR20110018317A (ko) * 2008-05-20 2011-02-23 아스트라제네카 아베 불안성 주요 우울 장애의 치료 방법
CN101906078B (zh) * 2009-06-08 2012-02-01 上海威智医药科技有限公司 噻唑衍生物的合成方法
CN102106807B (zh) * 2009-12-29 2013-03-27 上海中西制药有限公司 一种固体制剂的制备方法及所得固体制剂
WO2020061165A1 (en) 2018-09-21 2020-03-26 Garland Industries, Inc. Helical hardbanding

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2898339A (en) 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US4581171A (en) 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
EP1049676B1 (en) * 1997-12-24 2005-10-12 Ortho-Mcneil Pharmaceutical, Inc. 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
US6492375B2 (en) 1998-06-30 2002-12-10 Neuromed Technologies, Inc. Partially saturated calcium channel blockers
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
AU784848B2 (en) 1999-12-20 2006-07-06 Zalicus Pharmaceuticals Ltd. Partially saturated calcium channel blockers
BR0108965A (pt) * 2000-03-03 2002-11-26 Ortho Mcneil Pharm Inc Derivados de 3-(diarilmetileno)-8-azabiciclo[3,2,1]octano
SE0001208D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0101768D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
US20040204404A1 (en) 2002-09-30 2004-10-14 Robert Zelle Human N-type calcium channel blockers
SE0300105D0 (sv) * 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0301441D0 (sv) 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301442D0 (sv) 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
SE0301445D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301444D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
EP1641757A1 (en) * 2003-05-16 2006-04-05 AstraZeneca AB Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400025D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
WO2005087742A1 (en) 2004-03-08 2005-09-22 Exelixis, Inc. Metabolic kinase modulators and methods of use as pesticides
MY148880A (en) * 2006-10-20 2013-06-14 Astrazeneca Ab N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression

Also Published As

Publication number Publication date
BRPI0717631A2 (pt) 2013-10-29
DK2079735T3 (da) 2012-05-21
PL2079735T3 (pl) 2012-07-31
HK1131556A1 (es) 2010-01-29
PT2079735E (pt) 2012-05-07
CA2667041A1 (en) 2008-04-24
CL2007003009A1 (es) 2008-06-06
CA2667041C (en) 2011-09-06
IL197876A0 (en) 2009-12-24
EP2079735A4 (en) 2010-12-29
US7977355B2 (en) 2011-07-12
ES2379519T3 (es) 2012-04-26
RU2009111337A (ru) 2010-11-27
MY148880A (en) 2013-06-14
MX2009003974A (es) 2009-04-27
RS52260B (en) 2012-10-31
UY30652A1 (es) 2008-05-31
CY1112718T1 (el) 2016-02-10
CN101528739B (zh) 2011-11-30
AU2007313515B2 (en) 2010-11-25
NZ577060A (en) 2011-01-28
HRP20120344T1 (hr) 2012-05-31
PE20080892A1 (es) 2008-09-11
US7659286B2 (en) 2010-02-09
CN101528739A (zh) 2009-09-09
NO20091969L (no) 2009-05-20
RU2454414C2 (ru) 2012-06-27
CO6180450A2 (es) 2010-07-19
AR063345A1 (es) 2009-01-21
EP2079735A1 (en) 2009-07-22
WO2008048171A1 (en) 2008-04-24
UA97648C2 (ru) 2012-03-12
AU2010226996A1 (en) 2010-10-28
EP2079735B1 (en) 2012-02-01
KR20090065534A (ko) 2009-06-22
JP4668346B2 (ja) 2011-04-13
ATE543818T1 (de) 2012-02-15
US20080182875A1 (en) 2008-07-31
SI2079735T1 (sl) 2012-05-31
AU2007313515A1 (en) 2008-04-24
SA07280549B1 (ar) 2010-09-29
JP2010506910A (ja) 2010-03-04
US20100160374A1 (en) 2010-06-24
TW200826939A (en) 2008-07-01

Similar Documents

Publication Publication Date Title
PE20140634A1 (es) N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-iliden)metil)benzamida
NZ594597A (en) Substituted piperidines as ccr3 antagonists
IL269092A (en) Process for preparing 2-(9H-carbazole-4-yloxy)-4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine-1-yl )-N-({4-[(1-methylpiperidin-4-yl)amino]3-nitrophenyl}sulfonyl)benzamide
UY29575A1 (es) Formas polimórficas del éster etílico del ácido 3-((2-((4-(hexiloxicarbonilamino--imino-metil)-fenilamino)-metil)-1-metil-h-bencimidazol-5-carbonil)-piridin-2-il- -amino)-propiónico
UY30633A1 (es) 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridin-2-carboxamida monohidratada
NZ589010A (en) Pyrrole antifungal agents
AR060648A1 (es) Formas cristalinas de un compuesto de dimetilfenilo carbamoil etil piperidina
AR054734A1 (es) Compuesto que comprende monoclorhidrato de 1-[3-[3(4-clorofenil) propoxi] propil] - piperidina cristalino, procedimiento para su fabricacion y composiciones farmaceuticas.
CL2007002949A1 (es) Forma cristalina del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluoro-n-((metil(1-metiletil)amino)sulfonil)benzamida; proceso para la preparacion de dicha forma cristalina; composicion fitoprotectora;
DK2044043T4 (da) 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazinhydrobromid som en forbindelse med kombineret serotoningenoptag, 5-ht3 og 5-ht1a-aktivitet til behandling af kognitiv svækkelse
RS52306B (en) CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE CO-CRYSTALS
ATE455110T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
PE20091400A1 (es) Derivados de n-(2-amino-fenil)-amida como inhibidores de hdac
ECSP13012539A (es) ((r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol cristalino y su uso como inhibidor fgfr
DK2049475T3 (da) Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1
DK2049513T3 (da) Piperidinylsubstituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
PE20142355A1 (es) 1-pirazolil-3-(4-((2-anilinopirimidin-4-il)oxi)naftalen-1-il)ureas como inhibidores de proteinas cinasas activadas por mitogeno p38
AR082600A1 (es) Polimorfos cristalinos de la sal de besilato de n-(3-(5-fluor-2-(4-(2-metoxietoxi)fenilamino)pirimidin-4-ilamino)fenil)acrilamida, composiciones farmaceuticas que los contienen y uso de los mismos para tratar canceres, enfermedades autoinmunes y oseas, entre otras
WO2007066163A3 (en) Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
PE20100083A1 (es) Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
ATE457638T1 (de) Lösungsmittelzusammensetzung enthaltend mindestens zwei lösungsmittel, und pflanzenschutzformulierung, die diese zusammensetzung und einen wirkstoff enthält
RS52575B (en) PROCEDURE FOR THE MAKING OF MATRIX METALOPROTEINASE INHIBITORS AND THEIR CHIRAL ASSISTANTS
CL2009000256A1 (es) Imidazolinas fenil sustituidas, composicion farmaceutica que contenga estos compuestos y su uso en el sindrome metabolico, obesidad, diabetes, sindrome de stein-leventhal, transtornos del snc, esquizofrenia, alzheimer, dependencia al alcohol y dependencia a la nicotina.
UY32299A (es) Composiciones farmacéuticas líquidas
CR20130181A (es) UNA COMPOSICIÓN QUE COMPRENDE 2-metilpropanotioato de S-[2-([[1-(2-etilbutil)ciclohexil]-carbonil]amino)fenilo] Y CROSCARMELOSA SODICA

Legal Events

Date Code Title Description
FA Abandonment or withdrawal